Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -459.70K | -488.50K | -523.50K | 369.60K | -1.40M |
| Total Depreciation and Amortization | 2.50K | 26.00K | 25.70K | 25.60K | 24.10K |
| Total Amortization of Deferred Charges | 61.30K | 79.20K | 81.30K | 68.80K | 57.20K |
| Total Other Non-Cash Items | -8.70K | -24.80K | 57.20K | -760.20K | 1.01M |
| Change in Net Operating Assets | 76.70K | 188.30K | 108.60K | 7.80K | -93.80K |
| Cash from Operations | -327.80K | -219.80K | -250.80K | -288.40K | -405.00K |
| Capital Expenditure | -- | 0.00 | 0.00 | 0.00 | -26.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | -25.00K | -- |
| Cash from Investing | -- | 0.00 | 0.00 | -25.00K | -26.10K |
| Total Debt Issued | 447.70K | 328.00K | 288.60K | 525.40K | 574.90K |
| Total Debt Repaid | -110.20K | -99.60K | -113.30K | -146.80K | -166.50K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 337.50K | 228.40K | 175.30K | 378.60K | 408.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.70K | 8.60K | -75.50K | 65.20K | -22.60K |